Literature DB >> 26389824

Epidemiologic Association Between FUT2 Secretor Status and Severe Rotavirus Gastroenteritis in Children in the United States.

Daniel C Payne1, Rebecca L Currier2, Mary A Staat2, Leila C Sahni3, Rangaraj Selvarangan4, Natasha B Halasa5, Janet A Englund6, Geoffrey A Weinberg7, Julie A Boom8, Peter G Szilagyi7, Eileen J Klein6, James Chappell5, Christopher J Harrison4, Barbara S Davidson2, Slavica Mijatovic-Rustempasic1, Mary D Moffatt4, Monica McNeal2, Mary Wikswo1, Michael D Bowen1, Ardythe L Morrow2, Umesh D Parashar1.   

Abstract

IMPORTANCE: A genetic polymorphism affecting FUT2 secretor status in approximately one-quarter of humans of European descent affects the expression of histo-blood group antigens on the mucosal epithelia of human respiratory, genitourinary, and digestive tracts. These histo-blood group antigens serve as host receptor sites necessary for attachment and infection of some pathogens, including norovirus.
OBJECTIVE: We investigated whether an association exists between FUT2 secretor status and laboratory-confirmed rotavirus infections in US children. DESIGN, SETTING, AND PARTICIPANTS: Multicenter case-control observational study involving active surveillance at 6 US pediatric medical institutions in the inpatient and emergency department clinical settings. We enrolled 1564 children younger than 5 years with acute gastroenteritis (diarrhea and/or vomiting) and 818 healthy controls frequency matched by age and month, from December 1, 2011, through March 31, 2013. MAIN OUTCOMES AND MEASURES: Paired fecal-saliva specimens were tested for rotavirus and for secretor status. Comparisons were made between rotavirus test-positive cases and healthy controls stratified by ethnicity and vaccination status. Adjusted multivariable analyses assessed the preventive association of secretor status against severe rotavirus gastroenteritis.
RESULTS: One (0.5%) of 189 rotavirus test-positive cases was a nonsecretor, compared with 188 (23%) of 818 healthy control participants (P < .001). Healthy control participants of Hispanic ethnicity were significantly less likely to be nonsecretors (13%) compared with healthy children who were not of Hispanic ethnicity (25%) (P < .001). After controlling for vaccination and other factors, children with the nonsecretor FUT2 polymorphism appeared statistically protected (98% [95% CI, 84%-100%]) against severe rotavirus gastroenteritis. CONCLUSIONS AND RELEVANCE: Severe rotavirus gastroenteritis was virtually absent among US children who had a genetic polymorphism that inactivates FUT2 expression on the intestinal epithelium. We observed a strong epidemiologic association among children with rotavirus gastroenteritis compared with healthy control participants. The exact cellular mechanism behind this epidemiologic association remains unclear, but evidence suggests that it may be rotavirus genotype specific. The lower prevalence of nonsecretors among Hispanic children may translate to an enhanced burden of rotavirus gastroenteritis among this group. Our findings may have bearing on our full understanding of rotavirus infections and the effects of vaccination in diverse populations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26389824      PMCID: PMC4856001          DOI: 10.1001/jamapediatrics.2015.2002

Source DB:  PubMed          Journal:  JAMA Pediatr        ISSN: 2168-6203            Impact factor:   26.796


  33 in total

1.  Characterization of nontypeable rotavirus strains from the United States: identification of a new rotavirus reassortant (P2A[6],G12) and rare P3[9] strains related to bovine rotaviruses.

Authors:  D D Griffin; T Nakagomi; Y Hoshino; O Nakagomi; C D Kirkwood; U D Parashar; R I Glass; J R Gentsch
Journal:  Virology       Date:  2002-03-15       Impact factor: 3.616

2.  Norwalk virus infection and disease is associated with ABO histo-blood group type.

Authors:  Anne M Hutson; Robert L Atmar; David Y Graham; Mary K Estes
Journal:  J Infect Dis       Date:  2002-04-16       Impact factor: 5.226

3.  Determination of the 50% human infectious dose for Norwalk virus.

Authors:  Robert L Atmar; Antone R Opekun; Mark A Gilger; Mary K Estes; Sue E Crawford; Frederick H Neill; Sasirekha Ramani; Heather Hill; Jennifer Ferreira; David Y Graham
Journal:  J Infect Dis       Date:  2013-11-18       Impact factor: 5.226

4.  Enteric bacteria promote human and mouse norovirus infection of B cells.

Authors:  Melissa K Jones; Makiko Watanabe; Shu Zhu; Christina L Graves; Lisa R Keyes; Katrina R Grau; Mariam B Gonzalez-Hernandez; Nicole M Iovine; Christiane E Wobus; Jan Vinjé; Scott A Tibbetts; Shannon M Wallet; Stephanie M Karst
Journal:  Science       Date:  2014-11-07       Impact factor: 47.728

5.  Association between norovirus and rotavirus infection and histo-blood group antigen types in Vietnamese children.

Authors:  Nguyen Van Trang; Hau ThiBich Vu; Nhung ThiHong Le; Pengwei Huang; Xi Jiang; Dang Duc Anh
Journal:  J Clin Microbiol       Date:  2014-02-12       Impact factor: 5.948

6.  Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011.

Authors:  Daniel C Payne; Julie A Boom; Mary Allen Staat; Kathryn M Edwards; Peter G Szilagyi; Eileen J Klein; Rangaraj Selvarangan; Parvin H Azimi; Christopher Harrison; Mary Moffatt; Samantha H Johnston; Leila C Sahni; Carol J Baker; Marcia A Rench; Stephanie Donauer; Monica McNeal; James Chappell; Geoffrey A Weinberg; Azadeh Tasslimi; Jacqueline E Tate; Mary Wikswo; Aaron T Curns; Iddrisu Sulemana; Slavica Mijatovic-Rustempasic; Mathew D Esona; Michael D Bowen; Jon R Gentsch; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2013-03-13       Impact factor: 9.079

7.  Human susceptibility and resistance to Norwalk virus infection.

Authors:  Lisa Lindesmith; Christine Moe; Severine Marionneau; Nathalie Ruvoen; Xi Jiang; Lauren Lindblad; Paul Stewart; Jacques LePendu; Ralph Baric
Journal:  Nat Med       Date:  2003-04-14       Impact factor: 53.440

8.  A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype.

Authors:  Berthe-Marie Imbert-Marcille; Laure Barbé; Mathilde Dupé; Béatrice Le Moullac-Vaidye; Bernard Besse; Cécile Peltier; Nathalie Ruvoën-Clouet; Jacques Le Pendu
Journal:  J Infect Dis       Date:  2013-11-25       Impact factor: 5.226

Review 9.  Promise and pitfalls of the Immunochip.

Authors:  Adrian Cortes; Matthew A Brown
Journal:  Arthritis Res Ther       Date:  2011-02-01       Impact factor: 5.156

10.  Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen.

Authors:  Liya Hu; Sue E Crawford; Rita Czako; Nicolas W Cortes-Penfield; David F Smith; Jacques Le Pendu; Mary K Estes; B V Venkataram Prasad
Journal:  Nature       Date:  2012-04-15       Impact factor: 49.962

View more
  61 in total

Review 1.  Prevention of Necrotizing Enterocolitis Through Manipulation of the Intestinal Microbiota of the Premature Infant.

Authors:  Kannikar Vongbhavit; Mark A Underwood
Journal:  Clin Ther       Date:  2016-02-09       Impact factor: 3.393

Review 2.  Structural features of glycan recognition among viral pathogens.

Authors:  Sreejesh Shanker; Liya Hu; Sasirekha Ramani; Robert L Atmar; Mary K Estes; B V Venkataram Prasad
Journal:  Curr Opin Struct Biol       Date:  2017-06-04       Impact factor: 6.809

3.  Human VP8* mAbs neutralize rotavirus selectively in human intestinal epithelial cells.

Authors:  Ningguo Feng; Liya Hu; Siyuan Ding; Mrinmoy Sanyal; Boyang Zhao; Banumathi Sankaran; Sasirekha Ramani; Monica McNeal; Linda L Yasukawa; Yanhua Song; B V Venkataram Prasad; Harry B Greenberg
Journal:  J Clin Invest       Date:  2019-08-12       Impact factor: 14.808

Review 4.  Epithelial glycosylation in gut homeostasis and inflammation.

Authors:  Yoshiyuki Goto; Satoshi Uematsu; Hiroshi Kiyono
Journal:  Nat Immunol       Date:  2016-10-19       Impact factor: 25.606

Review 5.  Human Genetic Determinants of Viral Diseases.

Authors:  Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount
Journal:  Annu Rev Genet       Date:  2017-08-30       Impact factor: 16.830

6.  Naturally Acquired Immunity Against Rotavirus Infection and Gastroenteritis in Children: Paired Reanalyses of Birth Cohort Studies.

Authors:  Joseph A Lewnard; Benjamin A Lopman; Umesh D Parashar; Naor Bar-Zeev; Prasanna Samuel; M Lourdes Guerrero; Guillermo M Ruiz-Palacios; Gagandeep Kang; Virginia E Pitzer
Journal:  J Infect Dis       Date:  2017-08-01       Impact factor: 5.226

7.  Common homozygosity for predicted loss-of-function variants reveals both redundant and advantageous effects of dispensable human genes.

Authors:  Antonio Rausell; Yufei Luo; Marie Lopez; Yoann Seeleuthner; Franck Rapaport; Antoine Favier; Peter D Stenson; David N Cooper; Etienne Patin; Jean-Laurent Casanova; Lluis Quintana-Murci; Laurent Abel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-06-02       Impact factor: 11.205

8.  Shedding of porcine circovirus type 1 DNA and rotavirus RNA by infants vaccinated with Rotarix®.

Authors:  Slavica Mijatovic-Rustempasic; Lilly Cheng Immergluck; Trisha Chan Parker; Elham Laghaie; Anaam Mohammed; Terri McFadden; Umesh D Parashar; Michael D Bowen; Margaret M Cortese
Journal:  Hum Vaccin Immunother       Date:  2016-12-09       Impact factor: 3.452

9.  FUT2 Genetic Variants and Reported Respiratory and Gastrointestinal Illnesses During Infancy.

Authors:  Sheila J Barton; Robert Murray; Karen A Lillycrop; Hazel M Inskip; Nicholas C Harvey; Cyrus Cooper; Neerja Karnani; Irma Silva Zolezzi; Norbert Sprenger; Keith M Godfrey; Aristea Binia
Journal:  J Infect Dis       Date:  2019-02-15       Impact factor: 5.226

Review 10.  Human inborn errors of immunity to infection affecting cells other than leukocytes: from the immune system to the whole organism.

Authors:  Shen-Ying Zhang; Emmanuelle Jouanguy; Qian Zhang; Laurent Abel; Anne Puel; Jean-Laurent Casanova
Journal:  Curr Opin Immunol       Date:  2019-05-20       Impact factor: 7.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.